Company Filing History:
Years Active: 2022
Title: Wivine Burny: Innovator in HPV Treatment
Introduction
Wivine Burny is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of medical research, particularly in the treatment of Human Papilloma Virus (HPV) infections. With a total of 2 patents, Burny is recognized for his innovative approaches to immunogenic compositions.
Latest Patents
Burny's latest patents focus on compositions and methods of treatment related to HPV. The first patent involves nucleic acid constructs capable of encoding antigenic peptides or polypeptides derived from multiple HPV early proteins. This invention aims to create immunogenic compositions that can be used in treating persistent HPV infections and low-grade HPV lesions, especially in human anogenital epithelial tissue, such as cervical epithelia. The second patent also centers on nucleotide constructs encoding antigenic peptides or polypeptides from HPV early proteins, along with immunogenic compositions and their applications.
Career Highlights
Wivine Burny is currently associated with GlaxoSmithKline Biologicals SA, where he continues to advance his research in HPV treatment. His work has been instrumental in developing new therapeutic strategies that could potentially improve patient outcomes.
Collaborations
Burny collaborates with talented professionals in his field, including Cindy Castado and Sandra Giannini. These partnerships enhance the research and development efforts at GlaxoSmithKline Biologicals SA.
Conclusion
Wivine Burny stands out as an innovative inventor dedicated to improving treatments for HPV infections. His contributions through patents and collaborations reflect his commitment to advancing medical science.